To be honest, I'm tempted to look at how I can self fund a dexcom off the back of this.
I think we are providing a lot of data to Abbott that they should have already had. I think the test period they undertook was a joke without enough people involved to truly reflect a significant proportion of the users and that we are bearing the brunt of it now. They put something out onto the market that is just good enough, bit not really production ready.
In many ways this is very like what we see from Google or Microsoft. If this was a Beta version officially, I think we'd agree with some of the issues we're seeing. It's supposed to be production ready, which is much more of an issue.
I've come around to the point of view that we are really beta testing and that it will therefore work 80% of the time, and my definition of 80% is that one in five sensors will fail.
I think we are providing a lot of data to Abbott that they should have already had. I think the test period they undertook was a joke without enough people involved to truly reflect a significant proportion of the users and that we are bearing the brunt of it now. They put something out onto the market that is just good enough, bit not really production ready.
In many ways this is very like what we see from Google or Microsoft. If this was a Beta version officially, I think we'd agree with some of the issues we're seeing. It's supposed to be production ready, which is much more of an issue.
I've come around to the point of view that we are really beta testing and that it will therefore work 80% of the time, and my definition of 80% is that one in five sensors will fail.